WallStSmart

Diebold Nixdorf, Incorporated (DBD)vsQuhuo Limited (QH)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Diebold Nixdorf, Incorporated generates 53% more annual revenue ($3.87B vs $2.53B). DBD leads profitability with a 2.9% profit margin vs -5.9%. DBD earns a higher WallStSmart Score of 54/100 (C-).

DBD

Buy

54

out of 100

Grade: C-

Growth: 6.0Profit: 5.5Value: 5.3Quality: 5.0
Piotroski: 4/9Altman Z: 1.57

QH

Avoid

34

out of 100

Grade: F

Growth: 2.0Profit: 2.0Value: 5.0Quality: 4.0
Piotroski: 1/9Altman Z: 0.24

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DBD2 strengths · Avg: 8.0/10
Price/BookValuation
2.3x8/10

Reasonable price relative to book value

EPS GrowthGrowth
34.2%8/10

Earnings expanding 34.2% YoY

QH2 strengths · Avg: 10.0/10
Market CapQuality
$308.10B10/10

Mega-cap, among the largest globally

Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Areas to Watch

DBD4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
1.7%4/10

1.7% revenue growth

Altman Z-ScoreHealth
1.574/10

Distress zone — elevated risk

Profit MarginProfitability
2.9%3/10

2.9% margin — thin

Debt/EquityHealth
1.143/10

Elevated debt levels

QH4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

Return on EquityProfitability
-42.1%2/10

ROE of -42.1% — below average capital efficiency

Revenue GrowthGrowth
-2.3%2/10

Revenue declined 2.3%

EPS GrowthGrowth
-68.8%2/10

Earnings declined 68.8%

Comparative Analysis Report

WallStSmart Research

Bull Case : DBD

The strongest argument for DBD centers on Price/Book, EPS Growth.

Bull Case : QH

The strongest argument for QH centers on Market Cap, Price/Book.

Bear Case : DBD

The primary concerns for DBD are Revenue Growth, Altman Z-Score, Profit Margin. Thin 2.9% margins leave little buffer for downturns.

Bear Case : QH

The primary concerns for QH are Piotroski F-Score, Return on Equity, Revenue Growth.

Key Dynamics to Monitor

DBD profiles as a value stock while QH is a turnaround play — different risk/reward profiles.

DBD carries more volatility with a beta of 1.19 — expect wider price swings.

DBD is growing revenue faster at 1.7% — sustainability is the question.

QH generates stronger free cash flow (1M), providing more financial flexibility.

Bottom Line

DBD scores higher overall (54/100 vs 34/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Diebold Nixdorf, Incorporated

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Diebold Nixdorf, Incorporated provides connected commerce solutions to financial institutions and retailers in Western Europe, Eastern Europe, Asia, the Middle East, Africa, the United States, Canada, Mexico and Latin America. The company is headquartered in North Canton, Ohio.

Quhuo Limited

TECHNOLOGY · SOFTWARE - APPLICATION · China

Quhuo Limited, operates an operational solutions platform for the workforce in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.

Visit Website →

Want to dig deeper into these stocks?